2013Medical Innovation of ChinaRequires access

Clinical Observation of Integrated Medicine Therapy in Ulcerative Colitis

LI Sheng-x

Open publisher page 0 citations

Abstract

Objective:To explore the clinical efficacy of integrated medicine in patients with ulcerative colitis. Method:80 ulcerative colitis patients from August 2011 to August 2013 were selected and randomly divided into observation group and control group,each group contained 40 cases. The control group was separately assigned sulfasalazine pyridine,the observation group was given integrated medicine treatment. The clinical efficacy were compared between the two groups. Result:The total effective rate of the observation group was 97.5%,while the total effective rate of control group was 85.0%. The total effective rate of observation group was significantly higher than that of the control group,the difference was statistically significant(P0.05). Conclusion:Integrated medicine in the treatment of ulcerative colitis has a significant effect. It can rapidly improve the clinical symptoms. It is worth for clinical application and promotion.

About this research paper

What this paper is about

Objective:To explore the clinical efficacy of integrated medicine in patients with ulcerative colitis. Method:80 ulcerative colitis patients from August 2011 to August 2013 were selected and randomly divided into observation group and control group,each group contained 40 cases. The control group was separately assigned sulfasalazine pyridine,the observation group was given integrated medicine treatment. The clinical efficacy were compared between the two groups. Result:The total effective rate of the observation group was 97.5%,while the total effective rate of control group was 85.0%. The total effective rate of observation group was significantly higher than that of the control group,the difference was statistically significant(P0.05). Conclusion:Integrated medicine in the treatment of ulcerative colitis has a significant effect. It can rapidly improve the clinical symptoms. It is worth for clinical application and promotion.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the clinical efficacy of integrated medicine in patients with ulcerative colitis. Method:80 ulcerative colitis patients from August 2011 to August 2013 were selected and randomly divided into observation group and control group,each group contained 40 cases. The control group was separately assigned sulfasalazine pyridine,the observation group was given integrated medicine treatment. The clinical efficacy were compared between the two groups. Result:The total effective rate of the observation group was 97.5%,while the total effective rate of control group was 85.0%. The total effective rate of observation group was significantly higher than that of the control group,the difference was statistically significant(P0.05). Conclusion:Integrated medicine in the treatment of ulcerative colitis has a significant effect. It can rapidly improve the clinical symptoms. It is worth for clinical application and promotion.

Key concepts: Ulcerative colitis, Medicine, Sulfasalazine, Internal medicine, Gastroenterology, Clinical efficacy, Disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Observation of Integrated Medicine Therapy in Ulcerative Colitis — Research Paper | ScholarLens